Event
HBV (Hepatitis B Foundation) International Meeting
September 8 - September 12, 2025
Berlin, Germany
The International HBV Meeting continues to be the leading global forum dedicated exclusively to hepatitis B (HBV) and hepatitis D (HDV). This year’s program will highlight new scientific discoveries, innovative technologies, and collaborative approaches aimed at accelerating progress for people living with HBV.
Articles:
Anne Kasmar, M.D., M.Sc.
Senior Vice President, Global Therapeutic Area Head, Infectious Disease & Vaccines
Wednesday, September 10 from 8 – 9a.m.
Moderator
Title - Genome & epigenome editing in HBV: patient perspectives & regulatory requirements
The session will explore how patient perspectives, regulatory insights, and industry innovation can align to advance genome and epigenome editing approaches, strengthen trial design, and create new opportunities for accelerating treatments in HBV.
Action Items:
- Engage with people living with HBV: listen to #justB storytellers and explore resources from the Hepatitis B Foundation (http://www.hepb.org)
- Invite patient voices into your lab, team, or research programs
- Strengthen your regulatory knowledge through the FDA Clinical Investigator Training Course (CITC 2024) (https://www.fda.gov/drugs/news-events-human-drugs/fda-clinical-investigator-training-course-citc-2024-12102024)
- Become a champion for accelerating progress in HBV research and treatment
- Advocate for the EMA to convene a patient-focused drug development meeting for hepatitis B
Simona Stankeviciute, M.D., M.Sc.
Vice President, Technical
Wednesday, September 10 from 8 – 9a.m.
Panelist
Title - Genome & epigenome editing in HBV: patient perspectives & regulatory requirements
The session will explore how patient perspectives, regulatory insights, and industry innovation can align to advance genome and epigenome editing approaches, strengthen trial design, and create new opportunities for accelerating treatments in HBV.
Action Items:
- Engage with people living with HBV: listen to #justB storytellers and explore resources from the Hepatitis B Foundation (http://www.hepb.org)
- Invite patient voices into your lab, team, or research programs
- Strengthen your regulatory knowledge through the FDA Clinical Investigator Training Course (CITC 2024) (https://www.fda.gov/drugs/news-events-human-drugs/fda-clinical-investigator-training-course-citc-2024-12102024)
- Become a champion for accelerating progress in HBV research and treatment
- Advocate for the EMA to convene a patient-focused drug development meeting for hepatitis B
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.